学会発表（国際）

• Morita S and Matsuyama Y. Estimation of the average causal effect among subgroups defined by posttreatment variables. The 25th annual Conference of the International Society for Clinical Biostatistics (ISCB). 15- 19, August, 2004, Leiden, The Netherlands. Cont. 2003: 24(3S), 56S.
• Teramukai S, Matsuyama Y and Mizuno S. Exploring between study heterogeneity in individual patient data meta-analysis. The 3rd joint meeting of the International Society for Clinical Biostatistics (ISCB) and Society for Clinical Trials (SCT). London, UK. 20th-24th, July, 2003 Controlled Clinical Trials. 2003: 24(3S), 112S.
• Matsuyama Y and Yamaguchi Y. Estimation of the marginal survival time in the presence of competing risks. The 3rd joint meeting of the International Society for Clinical Biostatistics (ISCB) and Society for Clinical Trials (SCT). London, UK. 20th-24th, July, 2003 Controlled Clinical Trials. 2003: 24(3S), 56S.
• Kikuchi M, Matsuyama Y, and Ide T. The cause and effect relationship between pancreatic ?-cell impairment or insulin resistance and the natural history of development of type 2 diabetes in the employees of a trade firm in Tokyo. 8th Annual Meeting of the European Association for the Study of Diabetes. Budapest, Hungary, 1-5/September, 2002
• Matsuyama Y. Sensitivity analysis for the estimation of rates of change with non-ignorable drop-out: An application to a randomized clinical trial of the vitamin D3. XXIst International Biometrics Conference. Freiburg, Germany, 21/July-26/July, 2002 Proceedings. 2002:132.
• Sato T and Matsuyama Y. Marginal structural models as a tool for standardization. XXIst International Biometrics Conference. Freiburg, Germany, 21/July-26/July, 2002 Proceedings. 2002:29.

TOP